Re­gen­eron en­ters ven­ture in­vest­ing with $500M, poach­es se­nior part­ner from ARCH

Re­gen­eron, the 35-year-old drug­mak­er still led by its co-founders, is get­ting in­to the ven­ture in­vest­ing are­na.

The New York phar­ma will com­mit $100 mil­lion per year for five years, it said Mon­day morn­ing. The drug­mak­er is the ex­clu­sive lim­it­ed part­ner for the fund, which launched this month un­der the name Re­gen­eron Ven­tures. It will in­vest in biotech star­tups, de­vices, tools and “en­abling tech­nolo­gies.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER